One of the most well-known examples is that, a large fraction of hereditary breast cancer, ovarian cancer, and prostate cancer, which are accounted for by BRCA1 and BRCA2 mutations, which are pivotal genes in HR150. This evidence concerns the gene BRCA2 and ovarian carcinoma.